Director and Head, R&D Programs
CEPI (Coalition for Epidemic Preparedness Innovations), DC, United States
Mandeep Singh Dhingra, MD is currently the Director and Head of R&D programs at CEPI (Coalition of Epidemic Preparedness Innovations). In this role he is responsible for overseeing the scientific decision making and strategic direction setting across all the programs that CEPI is currently supporting. Mandeep completed his medical training from India and was involved in active patient care and academics in India prior to joining the vaccine industry as a part of R&D.
Mandeep has more than 19 years of vaccine industry experience having worked in various roles in Clinical Development, R&D Strategy, Project Leadership, Pharmacovigilance, Clinical QA, Regulatory Affairs, and Medical Affairs initially at Shantha Biotechnics Limited in India and then within the Sanofi US vaccines group. Mandeep has worked on a variety of bacterial and viral vaccines (including novel and first in class vaccines) globally and across the complete development lifecycle of the vaccine (pre-clinical to launch) in LMIC and HIC settings. He has actively collaborated with a variety of national and supranational agencies plus Industry partners to lead and oversee the development of vaccines which are currently licensed globally and being used in routine and outbreak settings. Mandeep has also completed additional training in Business Management and Leadership from the Stanford University School of Business.
Disclosure(s): Sanofi: Ex Employee, Stocks/Bonds (Public Company)
Wednesday, October 22, 2025
3:15 PM - 4:30 PM US ET
695 - Vaccines for Emerging Pathogens
Wednesday, October 22, 2025
4:05 PM - 4:30 PM US ET